Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine whether targeted pharmacological improvement of
insulin sensitivity will normalize the associated elevations of thrombotic and inflammatory
cardiovascular disease (CVD) biomarkers in individuals with insulin resistance.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
National Center for Research Resources (NCRR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Takeda Pharmaceuticals North America, Inc.